Sinobioway Group

Enerkem Inc. is a cleantech company based in Montreal, Canada, specializing in the production of renewable biofuels and chemicals derived from waste materials. The company utilizes a proprietary thermochemical process to convert non-recyclable municipal solid waste into cellulosic ethanol and other renewable chemicals. Over a decade of research has validated Enerkem's technology, which addresses issues related to oil dependence and waste disposal. The company operates advanced facilities that support its business model of producing biofuels profitably from a diverse range of feedstocks. Enerkem is majority-owned by a mix of institutional and clean-technology investors, including various venture capital firms and industrial investors. With a workforce of approximately 170 employees across Canada and the United States, Enerkem is committed to transforming waste into sustainable energy solutions.

Exuma Biotech is a clinical-stage biotechnology company focused on discovering and developing adoptive cellular therapies for solid tumors and hematological malignancies. Established in 2015 and headquartered in West Palm Beach, Florida, with additional locations in San Diego, California, Grand Cayman, and Shanghai, Exuma Biotech specializes in chimeric antigen receptor-T cell (CAR-T) therapy. The company aims to enhance the immune system's ability to combat various solid tumor malignancies, including renal cell carcinoma, soft tissue sarcoma, and gastric cancer. Through its logic-gated CAR-T platform, Exuma Biotech seeks to improve patient access to innovative cell and gene therapies. The company has formed strategic partnerships to advance its research and development efforts.